The surge in Brigade Enterprises share came after the company launched a residential project 'Brigade Altius' in Chennai with a revenue potential of Rs 1,700 crore
Analyst at Elara Capital believe defense companies in India stand to benefit as the EU defence OEM turn to public and private defence firms to procure components and subsystems.
The northward move in the K&R Rail Engineering shares came after the company announced it has inked a memorandum of understanding (MoU) of up to Rs 5,000 crore, with Indian port Rail and Ropeway Corp
The rise in the Kalpataru Projects share price came after it announced that the company, along with its international subsidiaries have secured new orders of Rs 2,306 crore
The uptick initially in the Nykaa share price came after Zurich, Switzerland-based brokerage firm UBS upgraded Nykaa stock to 'Buy', from 'Neutral'
Galaxy Surfactants share rose after the company announced that through its group companies it has entered into a deal with one of its global customers for providing EPC services
Till 11:11 am; a combined 27.24 million equity shares representing 2.75 per cent of total equity of the company have changed hands on the NSE (26.35 million shares) and BSE (0.89 million shares).
The uptick in Zydus Life share price came after the company announced that it has received final approval from the USFDA to manufacture Dasatinib tabs, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg
The uptick in RIL's share price followed an upgrade from domestic brokerage firm Kotak Institutional Equities, which raised its rating to 'Buy' from 'Add'
Anand Rathi Wealth informed the stock exchanges that its promoters have sold 250,000 equity shares representing 0.6 per cent holding of the company via open market.
The rise in Biocon share price came after the company announced that its wholly-owned subsidiary, Biocon Pharma, has received final approvals for Lenalidomide capsules and Dasatinib tabs from USFDA
According to Ambreesh Baliga, an independent analyst, "It's essentially a pullback rally following a prolonged decline in the Indian market."
Biocon: The company's subsidiary, Biocon Pharma, has received USFDA approvals for Lenalidomide capsules and Dasatinib tablets, and tentative approval for Rivaroxaban tablets
Stock Markets Today: As of 6:31 AM, GIFT Nifty Futures were down 54 points at 22,137, hinting at a negative start.
As of 6:40 AM, GIFT Nifty Futures were up 79 points at 22,359, hinting at a higher start
The current P/E is only marginally higher than the July 2016 levels, when it stood at 20.3x
Notably, stocks like Infosys, M&M, Bharti Airtel, TCS, and HCLTech were the top contributors to the downward pressure on the indices
Despite the optimism surrounding growth, many brokerages are concerned about Jubilant FoodWorks' margin outlook
The downfall in the LIC share price came after the company announced that it has received a communication/demand order for GST, interest and penalty for Maharashtra state worth about Rs 480 crore
Stock Market Today: At 6:50 AM, GIFT Nifty Futures were down 148 points at 22,536, hinting at a gap-down start